{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:25:54Z","timestamp":1770834354396,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04529-x","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:34:27Z","timestamp":1768581267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages"],"prefix":"10.1186","volume":"27","author":[{"given":"Jiebo","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingmei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"3","key":"4529_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","volume":"11","author":"D Nguyen","year":"2006","unstructured":"Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ. Macrophage accumulation in human progressive diabetic nephropathy. Nephrol (Carlton). 2006;11(3):226\u201331. https:\/\/doi.org\/10.1111\/j.1440-1797.2006.00576.x.","journal-title":"Nephrol (Carlton)"},{"issue":"12","key":"4529_CR2","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/ndt\/gfh441","volume":"19","author":"FY Chow","year":"2004","unstructured":"Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transpl. 2004;19(12):2987\u201396. https:\/\/doi.org\/10.1093\/ndt\/gfh441.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4529_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000334928","volume":"35","author":"JY Moon","year":"2012","unstructured":"Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol. 2012;35(2):164\u201374. https:\/\/doi.org\/10.1159\/000334928.","journal-title":"Am J Nephrol"},{"issue":"8","key":"4529_CR4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/ndt\/gfw260","volume":"32","author":"CQF Klessens","year":"2017","unstructured":"Klessens CQF, Zandbergen M, Wolterbeek R, Bruijn JA, Rabelink TJ, Bajema IM, et al. Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol Dial Transpl. 2017;32(8):1322\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfw260.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"4529_CR5","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler R, Afkarian M, Dieter BP, Tuttle KR. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Ren Physiol. 2017;312(4):F716\u201331. https:\/\/doi.org\/10.1152\/ajprenal.00314.2016.","journal-title":"Am J Physiol Ren Physiol"},{"key":"4529_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.intimp.2018.03.019","volume":"58","author":"Z Fan","year":"2018","unstructured":"Fan Z, Wang Y, Xu X, Wu Y. Inhibitor of bruton\u2019s tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators\u2019 production in high glucose-induced macrophages. Int Immunopharmacol. 2018;58:145\u201353. https:\/\/doi.org\/10.1016\/j.intimp.2018.03.019.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"4529_CR7","doi-asserted-by":"publisher","first-page":"F1719","DOI":"10.1152\/ajprenal.00141.2013","volume":"305","author":"H You","year":"2013","unstructured":"You H, Gao T, Cooper TK, Brian Reeves W, Awad AS. Macrophages directly mediate diabetic renal injury. Am J Physiol Ren Physiol. 2013;305(12):F1719\u201327. https:\/\/doi.org\/10.1152\/ajprenal.00141.2013.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"4529_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ndt\/gft305","volume":"29","author":"A Eirin","year":"2014","unstructured":"Eirin A, Zhang X, Zhu XY, Tang H, Jordan KL, Grande JP, et al. Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrol Dial Transpl. 2014;29(2):274\u201382. https:\/\/doi.org\/10.1093\/ndt\/gft305.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4529_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1681\/ASN.2009060615","volume":"22","author":"S Lee","year":"2011","unstructured":"Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22(2):317\u201326. https:\/\/doi.org\/10.1681\/ASN.2009060615.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4529_CR10","doi-asserted-by":"publisher","first-page":"e0221991","DOI":"10.1371\/journal.pone.0221991","volume":"14","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yang Y, Zhao Y. Macrophage phenotype and its relationship with renal function in human diabetic nephropathy. PLoS ONE. 2019;14(9):e0221991. https:\/\/doi.org\/10.1371\/journal.pone.0221991.","journal-title":"PLoS ONE"},{"issue":"6","key":"4529_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.coi.2005.09.002","volume":"17","author":"JA Bluestone","year":"2005","unstructured":"Bluestone JA, Tang Q. How do CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells control autoimmunity? Curr Opin Immunol. 2005;17(6):638\u201342. https:\/\/doi.org\/10.1016\/j.coi.2005.09.002.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"4529_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363. https:\/\/doi.org\/10.1681\/ASN.2010010010.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"4529_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953\u201364. https:\/\/doi.org\/10.1038\/nri1733.","journal-title":"Nat Rev Immunol"},{"key":"4529_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2741\/2734","volume":"13","author":"C Ruster","year":"2008","unstructured":"Ruster C, Wolf G. The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci. 2008;13:944\u201355. https:\/\/doi.org\/10.2741\/2734.","journal-title":"Front Biosci"},{"issue":"11","key":"4529_CR15","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.ajpath.2017.07.020","volume":"187","author":"MGS Boels","year":"2017","unstructured":"Boels MGS, Koudijs A, Avramut MC, Sol W, Wang G, van Oeveren-Rietdijk AM, et al. Systemic monocyte chemotactic Protein-1 Inhibition modifies renal macrophages and restores glomerular endothelial glycocalyx and barrier function in diabetic nephropathy. Am J Pathol. 2017;187(11):2430\u201340. https:\/\/doi.org\/10.1016\/j.ajpath.2017.07.020.","journal-title":"Am J Pathol"},{"issue":"11","key":"4529_CR16","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1172\/JCI36150","volume":"118","author":"SD Ricardo","year":"2008","unstructured":"Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest. 2008;118(11):3522\u201330. https:\/\/doi.org\/10.1172\/JCI36150.","journal-title":"J Clin Invest"},{"issue":"2","key":"4529_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","volume":"73","author":"DM Mosser","year":"2003","unstructured":"Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003;73(2):209\u201312. https:\/\/doi.org\/10.1189\/jlb.0602325.","journal-title":"J Leukoc Biol"},{"issue":"20","key":"4529_CR18","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2174\/1381612824666180716163845","volume":"24","author":"RC Landis","year":"2018","unstructured":"Landis RC, Quimby KR, Greenidge AR. M1\/M2 macrophages in diabetic nephropathy: Nrf2\/HO-1 as therapeutic targets. Curr Pharm Des. 2018;24(20):2241\u20139. https:\/\/doi.org\/10.2174\/1381612824666180716163845.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"4529_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ki.2013.135","volume":"84","author":"J Lu","year":"2013","unstructured":"Lu J, Cao Q, Zheng D, Sun Y, Wang C, Yu X, et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int. 2013;84(4):745\u201355. https:\/\/doi.org\/10.1038\/ki.2013.135.","journal-title":"Kidney Int"},{"issue":"2","key":"4529_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1681\/ASN.2013020152","volume":"25","author":"M Lech","year":"2014","unstructured":"Lech M, Grobmayr R, Ryu M, Lorenz G, Hartter I, Mulay SR, et al. Macrophage phenotype controls long-term AKI outcomes\u2013kidney regeneration versus atrophy. J Am Soc Nephrol. 2014;25(2):292\u2013304. https:\/\/doi.org\/10.1681\/ASN.2013020152.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4529_CR21","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.kint.2022.08.026","volume":"102","author":"J Fu","year":"2022","unstructured":"Fu J, Sun Z, Wang X, Zhang T, Yuan W, Salem F, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291\u2013304. https:\/\/doi.org\/10.1016\/j.kint.2022.08.026.","journal-title":"Kidney Int"},{"issue":"5\u20136","key":"4529_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1159\/000336717","volume":"4","author":"M Weidenbusch","year":"2012","unstructured":"Weidenbusch M, Anders HJ. Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. J Innate Immun. 2012;4(5\u20136):463\u201377. https:\/\/doi.org\/10.1159\/000336717.","journal-title":"J Innate Immun"},{"key":"4529_CR23","doi-asserted-by":"publisher","first-page":"514738","DOI":"10.1155\/2011\/514738","volume":"2011","author":"CC Wu","year":"2011","unstructured":"Wu CC, Sytwu HK, Lu KC, Lin YF. Role of T cells in type 2 diabetic nephropathy. Exp Diabetes Res. 2011;2011:514738. https:\/\/doi.org\/10.1155\/2011\/514738.","journal-title":"Exp Diabetes Res"},{"issue":"10","key":"4529_CR24","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","volume":"53","author":"X Qin","year":"2004","unstructured":"Qin X, Goldfine A, Krumrei N, Grubissich L, Acosta J, Chorev M, et al. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes. 2004;53(10):2653\u201361. https:\/\/doi.org\/10.2337\/diabetes.53.10.2653.","journal-title":"Diabetes"},{"issue":"4","key":"4529_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11892-018-0984-6","volume":"18","author":"FB Hickey","year":"2018","unstructured":"Hickey FB, Martin F. Role of the immune system in diabetic kidney disease. Curr Diab Rep. 2018;18(4):20. https:\/\/doi.org\/10.1007\/s11892-018-0984-6.","journal-title":"Curr Diab Rep"},{"issue":"8","key":"4529_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri2138","volume":"7","author":"MG Roncarolo","year":"2007","unstructured":"Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7(8):585\u201398. https:\/\/doi.org\/10.1038\/nri2138.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4529_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/eji.200738104","volume":"38","author":"CM Costantino","year":"2008","unstructured":"Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol. 2008;38(4):921\u20134. https:\/\/doi.org\/10.1002\/eji.200738104.","journal-title":"Eur J Immunol"},{"issue":"6","key":"4529_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1681\/ASN.2009060592","volume":"21","author":"Q Cao","year":"2010","unstructured":"Cao Q, Wang Y, Zheng D, Sun Y, Wang Y, Lee VW, et al. IL-10\/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol. 2010;21(6):933\u201342. https:\/\/doi.org\/10.1681\/ASN.2009060592.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04529-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:53:49Z","timestamp":1770832429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04529-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics Committee of Shanghai Putuo District Central Hospital (REC reference no. PTEC-A-2019-19-1). Written informed consent was obtained from all participants. The study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}